Adjuvant therapy trials of radiotherapy and systemic treatment for breast cancer Betty A. MinceyLaura A. VallowEdith A. Perez Invited Commentary Pages: 1 - 1
Development of novel signal transduction inhibitors: Recent phase I trials Ronald M. Bukowski Clinical Trials Report Pages: 7 - 8
Tyrosine kinase inhibitors: A clinical perspective Sanjay GoelSridhar ManiRoman Perez-Soler OriginalPaper Pages: 9 - 19
Inhibition of vascular endothelial growth factor in the treatment of solid tumors Kim Margolin OriginalPaper Pages: 20 - 28
Evolving therapies: Farnesyltransferase inhibitors W. Thomas PurcellRoss C. Donehower OriginalPaper Pages: 29 - 36
An update on epidermal growth factor receptor inhibitors Shanu ModiAndrew D. Seidman OriginalPaper Pages: 47 - 55
Prevention of radiation-induced oral mucositis with benzydamine Ehab Y. Hanna Clinical Trials Report Pages: 65 - 67
Cancer of the external auditory canal and temporal bone Randall L. BreauEdward K. GardnerJohn L. Dornhoffer OriginalPaper Pages: 76 - 80
Management of the clinically negative (N0) neck Karen T. PitmanRobert Dean OriginalPaper Pages: 81 - 86